Rowlandmiller & Partners’s Bristol-Myers Squibb BMY Stock Holding History

Rowlandmiller & Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,476	Closed	-$102K	–	183
2023 Q1	$102K	Sell	1,476 -592	-29%	-$41.8K	0.02%	177
2022 Q4	$149K	Sell	2,068 -93	-4%	-$7.01K	0.04%	154
2022 Q3	$154K	Buy	2,161 +141	+7%	+$10.2K	0.04%	146
2022 Q2	$156K	Sell	2,020 -85	-4%	-$6.47K	0.04%	149
2022 Q1	$154K	Sell	2,105 -5,788	-73%	-$389K	0.04%	149
2021 Q4	$140K	Buy	7,893 +5,190	+192%	+$304K	0.03%	163
2021 Q3	$159K	Buy	2,703 +403	+18%	+$26.5K	0.05%	128
2021 Q2	$154K	Hold	2,300	–	–	0.04%	152
2021 Q1	$145K	Sell	2,300 -1,070	-32%	-$66.6K	0.04%	149
2020 Q4	$209K	Buy	3,370 +554	+20%	+$34.1K	0.06%	131
2020 Q3	$157K	Buy	2,816 +113	+4%	+$6.8K	0.06%	122
2020 Q2	$159K	Sell	2,703 -113	-4%	-$6.76K	0.05%	128
2020 Q1	$157K	Sell	2,816 -302	-10%	-$18.5K	0.06%	122
2019 Q4	$200K	Buy	3,118 +63	+2%	+$3.61K	0.06%	122
2019 Q3	$156K	Buy	+3,055	New	+$144K	0.05%	122
2019 Q2	–	Sell	-2,055	Closed	-$98K	–	136
2019 Q1	$98K	Sell	2,055 -300	-13%	-$14.9K	0.04%	133
2018 Q4	$122K	Sell	2,355 -400	-15%	-$21.5K	0.05%	124
2018 Q3	$171K	Hold	2,755	–	–	0.06%	117
2018 Q2	$152K	Sell	2,755 -150	-5%	-$8.1K	0.06%	117
2018 Q1	$184K	Sell	2,905 -2,860	-50%	-$184K	0.07%	111
2017 Q4	$355K	Sell	5,765 -100	-2%	-$6.25K	0.14%	87
2017 Q3	$372K	Buy	5,865 +40	+0.7%	+$2.34K	0.15%	79
2017 Q2	$326K	Hold	5,825	–	–	0.14%	85
2017 Q1	$316K	Sell	5,825 -300	-5%	-$16.5K	0.14%	86
2016 Q4	$358K	Sell	6,125 -400	-6%	-$21.9K	0.16%	76
2016 Q3	$352K	Sell	6,525 -25	-0.4%	-$1.61K	0.16%	78
2016 Q2	$482K	Sell	6,550 -505	-7%	-$35.7K	0.22%	67
2016 Q1	$451K	Sell	7,055 -40	-0.6%	-$2.52K	0.21%	69
2015 Q4	$476K	Hold	7,095	–	–	0.24%	66
2015 Q3	$416K	Sell	7,095 -200	-3%	-$12.7K	0.22%	67
2015 Q2	$485K	Sell	7,295 -75	-1%	-$4.94K	0.24%	68
2015 Q1	$467K	Sell	7,370 -50	-0.7%	-$3.13K	0.23%	70
2014 Q4	$438K	Buy	+7,420	New	+$418K	0.21%	69